___

• 1. Ankom MA, Shapiro JR. Paget's Disease of Bone (Osteitis Deformans). J Am Geriatr Soc 1998; 46:1025-33.
• 2. Siris ES. Epidemiological aspects of Paget's disease: Family history and relationship to other medical conditions. SeminArthritis Rheum 1994; 23: 222-5.
• 3. Haslam SI, Van Hul W, Morales-Piga A, Balemans W, San-Millan JL, Nakatsuka K, Willems P, Haites NE, Ralston SH. Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. J Bone Miner Res 1998; 13: 911- 7.
• 4. Tiegs RD. Paget's disease of bone: indications for treatment and goals of therapy. Clin Ther 1997 ; 19 : 1309-29.
• 5. Hamdy RC, Moore S, LeRoy J. Clinical presentation of Paget's disease of the bone in older patients. South Med J 1993; 86: 1097-1100.
• 6. BezzaA. Sacro-iliac involvement in the course of Paget disease. Report of 6 cases. Press Med 1999 ; 28 :1157-9.
• 7. Marcelli C. Pagetic vertebral ankylosis and diffuse idiopathic skeletal hyperostosis. Spine 1995 ; 20 : 454- 9.
• 8. Yost JH, Spencer-Green G, Krant JD. Vascular steal mimicking compression myelopathy in Paget's disease of bone: Rapid reversal with calcitonin and systemic steroids. J Rheumatol 1993; 20: 1064.
• 9. Fraser WD. Paget's disease of bone. Curr Opin Rheumatol 1997;9: 347-54.
• 10. Calvo MS, Eyre DR, Gundberg CM. Biological markers of bone turnover. Endocr Rev 1996; 17: 333- 68.
• 11. Alvarez L, Guanabens N, Peris P et al. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. J Bone Miner Res 1995;10: 458-465.
• 12. Altman RD. Paget's disease of bone: Rheumatologic complications. Bone 1999; 24 (Supp 5): 47 S-48S.
• 13. Siris ES. Goals of treatment for Paget's disease of bone. J Bone Miner Res 1999 ; 14 (Supp 2): 49-52